Chronic iron deficiency as an emerging risk factor for osteoporosis: A hypothesis

Nutrients

Volumn 7, Issue 4, 2015, Pages 2324-2344

  Toxqui, Laura ^a   Vaquero, M Pilar ^a  

^a INSTITUTE OF FOOD SCIENCE   (Spain)

Author keywords

Anemia; Bone formation; Bone health; Bone remodeling; Bone resorption; Iron deficiency; Iron overload; Osteoporosis; Vitamin D

Indexed keywords

2 OXOGLUTARIC ACID; 25 HYDROXYVITAMIN D; ANDROGEN; BONE MORPHOGENETIC PROTEIN; CALCITONIN; COLLAGEN TYPE 1; COLONY STIMULATING FACTOR 1; FERRITIN; FIBRONECTIN; HEMOGLOBIN; HEPCIDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; IRON; OSTEOCALCIN; OSTEONECTIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN B; SOMATOMEDIN C; THYROID HORMONE; TRANSFERRIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; IRON INTAKE;

BONE METABOLISM; BONE REMODELING; COGNITIVE DEFECT; GENE MUTATION; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON DEPLETION; IRON METABOLISM; IRON OVERLOAD; MENSTRUATION; NONHUMAN; OSSIFICATION; OSTEOCLAST ACTIVITY; OSTEOLYSIS; OSTEOPOROSIS; REVIEW; RICKETS; SIGNAL TRANSDUCTION; ADMINISTRATION AND DOSAGE; ANEMIA, IRON-DEFICIENCY; ANIMAL; BLOOD; BONE; CHRONIC DISEASE; COMPLICATION; DRUG EFFECTS; IRON INTAKE; METABOLISM; RISK FACTOR;

ANEMIA, IRON-DEFICIENCY; ANIMALS; BONE AND BONES; BONE REMODELING; BONE RESORPTION; CHRONIC DISEASE; HUMANS; IRON, DIETARY; OSTEOPOROSIS; RISK FACTORS;

EID: 84927941788     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7042324     Document Type: Review

References (102)

1. Denic, S.; Agarwal, M.M. Nutritional iron deficiency: An evolutionary perspective. Nutrition 2007, 23, 603-614.
2. Lieu, P.T.; Heiskala, M.; Peterson, P.A.; Yang, Y. The roles of iron in health and disease. Mol. Asp. Med. 2001, 22, 1-87.
3. Lynch, S. Iron metabolism. In The Guidebook Nutritional Anemia; Badham, J., Zimmerman, M.B., Kraemer, K., Eds.; SIGHT AND LIFE Press: Basel, Switzerland, 2007; pp. 17-18.
4. Worldwide Prevalence of Anaemia 1993-2005. WHO Global Database on Anaemia. WHO Library Cataloguing-in-Publication Data: 2008. Available online: http://whqlibdoc.who.int/ publications/2008/9789241596657_eng.pdf (accessed on 19 January 2015).
5. Zimmermann, M.B.; Hurrell, R.F. Nutritional iron deficiency. Lancet 2007, 370, 511-520.
6. McArthur, J.O.; Petocz, P.; Caterson, I.D.; Samman, S. A randomized controlled trial in young women of the effects of consuming pork meat or iron supplements on nutritional status and feeling of well-being. J. Am. Coll. Nutr. 2012, 31, 175-184.
7. Navas-Carretero, S.; Perez-Granados, A.M.; Sarria, B.; Carbajal, A.; Pedrosa, M.M.; Roe, M.A.; Fairweather-Tait, S.J.; Vaquero, M.P. Oily fish increases iron bioavailability of a phytate rich meal in young iron deficient women. J. Am. Coll. Nutr. 2008, 27, 96-101.
8. Navas-Carretero, S.; Perez-Granados, A.M.; Sarria, B.; Vaquero, M.P. Iron absorption from meat pate fortified with ferric pyrophosphate in iron-deficient women. Nutrition 2009, 25, 20-24.
9. Hurrell, R.; Egli, I. Iron bioavailability and dietary reference values. Am. J. Clin. Nutr. 2010, 91, 1461S-1467S.
10. Vaquero, M.P.; Blanco-Rojo, R.; Toxqui, L. Nutrición y anemia. In Manual Práctico de Nutrición y Salud; Carbajal-Azcona, A., Martínez-Roldán, C., Eds.; Exlibris, S.L.: Madrid, Spain, 2012; pp. 367-376.
11. Toxqui, L.; Perez-Granados, A.M.; Blanco-Rojo, R.; Wright, I.; Gonzalez-Vizcayno, C.; Vaquero, M.P. Effects of an iron or iron and vitamin d-fortified flavored skim milk on iron metabolism: A randomized controlled double-blind trial in iron-deficient women. J. Am. Coll. Nutr. 2013, 32, 312-320.
12. Monsen, E.R.; Hallberg, L.; Layrisse, M.; Hegsted, D.M.; Cook, J.D.; Mertz, W.; Finch, C.A. Estimation of available dietary iron. Am. J. Clin. Nutr. 1978, 31, 134-141.
13. Blanco-Rojo, R.; Toxqui, L.; Lopez-Parra, A.M.; Baeza-Richer, C.; Perez-Granados, A.M.; Arroyo-Pardo, E.; Vaquero, M.P. Influence of diet, menstruation and genetic factors on iron status: A cross-sectional study in Spanish women of childbearing age. Int. J. Mol. Sci. 2014, 15, 4077-4087.
14. Toxqui, L.; Perez-Granados, A.M.; Blanco-Rojo, R.; Wright, I.; Vaquero, M.P. A simple and feasible questionnaire to estimate menstrual blood loss: Relationship with hematological and gynecological parameters in young women. BMC Women's Health 2014, 14, 71.
15. Harvey, L.J.; Armah, C.N.; Dainty, J.R.; Foxall, R.J.; John Lewis, D.; Langford, N.J.; Fairweather-Tait, S.J. Impact of menstrual blood loss and diet on iron deficiency among women in the uk. Br. J. Nutr. 2005, 94, 557-564.
16. Goddard, A.F.; McIntyre, A.S.; Scott, B.B. Guidelines for the management of iron deficiency anaemia. British society of gastroenterology. Gut 2000, 46 (Suppl. 3-4), IV1-IV5.
17. Sarria, B.; Navas-Carretero, S.; Lopez-Parra, A.M.; Perez-Granados, A.M.; Arroyo-Pardo, E.; Roe, M.A.; Teucher, B.; Vaquero, M.P.; Fairweather-Tait, S.J. The G277S transferrin mutation does not affect iron absorption in iron deficient women. Eur. J. Nutr. 2007, 46, 57-60.
18. Benyamin, B.; McRae, A.F.; Zhu, G.; Gordon, S.; Henders, A.K.; Palotie, A.; Peltonen, L.; Martin, N.G.; Montgomery, G.W.; Whitfield, J.B.; et al. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. Am. J. Hum. Genet. 2009, 84, 60-65.
19. Blanco-Rojo, R.; Baeza-Richer, C.; Lopez-Parra, A.M.; Perez-Granados, A.M.; Brichs, A.; Bertoncini, S.; Buil, A.; Arroyo-Pardo, E.; Soria, J.M.; Vaquero, M.P. Four variants in transferrin and hfe genes as potential markers of iron deficiency anaemia risk: An association study in menstruating women. Nutr. Metab. 2011, 8, 69.
20. Blanco-Rojo, R.; Bayele, H.K.; Srai, S.K.; Vaquero, M.P. Intronic snp rs3811647 of the human transferrin gene modulates its expression in hepatoma cells. Nutr Hosp. 2012, 27, 2142-2145.
21. Baeza-Richer, C.; Blanco-Rojo, R.; Lopez-Parra, A.M.; Brichs, A.; Bertoncini, S.; Perez-Granados, A.M.; Buil, A.; Soria, J.M.; Arroyo-Pardo, E.; Vaquero, M.P. Identification of a novel quantitative trait nucleotype related to iron status in a calcium channel gene. Dis. Mark. 2013, 34, 121-129.
22. Iron Deficiency Anaemia Assessment, Prevention, and Control. A Guide for Programme Managers; United Nations Children's Fund; United Nations University; World Health Organization. Available online: http://www.who.int/nutrition/publications/micronutrients/ anaemia_iron_deficiency/WHO_NHD_01.3/en/ (accessed on 19 January 2015).
23. Jauregui-Lobera, I. Iron deficiency and cognitive functions. Neuropsychiatr. Dis. Treat. 2014, 10, 2087-2095.
24. Jonker, F.A.; Boele van Hensbroek, M. Anaemia, iron deficiency and susceptibility to infections. J. Infect. 2014, 69 (Suppl. 1), S23-S27.
25. Buratti, P.; Gammella, E.; Rybinska, I.; Cairo, G.; Recalcati, S. Recent advances in iron metabolism: Relevance for health, exercise, and performance. Med. Sci. Sports Exerc. 2014, in press.
26. Gibson, R.S. Assesment of iron status. In Principles of Nutritional Assessment; Gibson, R.S., Ed.; Oxford University Press: New York, NY, USA, 2005; pp. 446-469.
27. Abbaspour, N.; Hurrell, R.; Kelishadi, R. Review on iron and its importance for human health. J. Res. Med. Sci. 2014, 19, 164-174.
28. Toxqui, L.; de Piero, A.; Courtois, V.; Bastida, S.; Sanchez-Muniz, F.J.; Vaquero, M.P. Iron deficiency and overload. Implications in oxidative stress and cardiovascular health. Nutr. Hosp. 2010, 25, 350-365.
29. Ganz, T. Iron homeostasis: Fitting the puzzle pieces together. Cell Metab. 2008, 7, 288-290.
30. Ganz, T. Hepcidin and iron regulation, 10 years later. Blood 2011, 117, 4425-4433.
31. Proff, P.; Romer, P. The molecular mechanism behind bone remodelling: A review. Clin. Oral Investig. 2009, 13, 355-362.
32. Manolagas, S.C. Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 2000, 21, 115-137.
33. Boyce, B.F.; Rosenberg, E.; de Papp, A.E.; Duong le, T. The osteoclast, bone remodelling and treatment of metabolic bone disease. Eur. J. Clin. Investig. 2012, 42, 1332-1341.
34. Kular, J.; Tickner, J.; Chim, S.M.; Xu, J. An overview of the regulation of bone remodelling at the cellular level. Clin. Biochem. 2012, 45, 863-873.
35. Reynaga-Montecinos, B.; Zeni, N. Biochemical markers of bone remodelling. Clinical utility. Acta Bioquím. Clín. Latinoam. 2009, 43, 177-193. (in Spanish)
36. Nakashima, T.; Hayashi, M.; Fukunaga, T.; Kurata, K.; Oh-Hora, M.; Feng, J.Q.; Bonewald, L.F.; Kodama, T.; Wutz, A.; Wagner, E.F.; et al. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 2011, 17, 1231-1234.
37. Schaffler, M.B.; Cheung, W.Y.; Majeska, R.; Kennedy, O. Osteocytes: Master orchestrators of bone. Calcif. Tissue Int. 2014, 94, 5-24.
38. Bonewald, L.F. The amazing osteocyte. J. Bone Miner. Res. 2011, 26, 229-238.
39. Martin, T.J.; Sims, N.A. RANKL/OPG; critical role in bone physiology. Rev. Endocr. Metab. Disord. 2015, in press.
40. Simonet, W.S.; Lacey, D.L.; Dunstan, C.R.; Kelley, M.; Chang, M.S.; Luthy, R.; Nguyen, H.Q.; Wooden, S.; Bennett, L.; Boone, T.; et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997, 89, 309-319.
41. Boyce, B.F.; Xing, L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 2008, 473, 139-146.
42. Hadjidakis, D.J.; Androulakis, II. Bone remodeling. Ann. N. Y. Acad. Sci. 2006, 1092, 385-396.
43. Matsuo, K.; Irie, N. Osteoclast-osteoblast communication. Arch. Biochem. Biophys. 2008, 473, 201-209.
44. Seeman, E. Bone modeling and remodeling. Crit. Rev. Eukaryot. Gene Expr. 2009, 19, 219-233.
45. Lorget, F.; Kamel, S.; Mentaverri, R.; Wattel, A.; Naassila, M.; Maamer, M.; Brazier, M. High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochem. Biophys. Res. Commun. 2000, 268, 899-903.
46. Baim, S.; Miller, P.D. Assessing the clinical utility of serum ctx in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. J. Bone Min. Res. 2009, 24, 561-574.
47. Shoulders, M.D.; Raines, R.T. Collagen structure and stability. Ann. Rev. Biochem. 2009, 78, 929-958.
48. Gorres, K.L.; Raines, R.T. Prolyl 4-hydroxylase. Crit. Rev. Biochem. Mol. Biol. 2010, 45, 106-124.
49. Tuderman, L.; Myllyla, R.; Kivirikko, K.I. Mechanism of the prolyl hydroxylase reaction. 1. Role of co-substrates. Eur. J. Biochem. 1977, 80, 341-348.
50. De Jong, L.; Kemp, A. Stoicheiometry and kinetics of the prolyl 4-hydroxylase partial reaction. Biochim. Biophys. Acta 1984, 787, 105-111.
51. Pikuleva, I.A.; Waterman, M.R. Cytochromes P450: Roles in diseases. J. Biol. Chem. 2013, 288, 17091-17098.
52. Sakaki, T.; Kagawa, N.; Yamamoto, K.; Inouye, K. Metabolism of vitamin D3 by cytochromes P450. Front. Biosci. 2005, 10, 119-134.
53. Dong, Q.; Miller, W.L. Vitamin D 25-hydroxylase deficiency. Mol. Genet. Metab. 2004, 83, 197-198.
54. Holick, M.F. Vitamin D status: Measurement, interpretation, and clinical application. Ann. Epidemiol. 2009, 19, 73-78.
55. Holick, M.F.; Chen, T.C. Vitamin D deficiency: A worldwide problem with health consequences. Am. J. Clin. Nutr. 2008, 87, 1080S-1086S.
56. Fu, G.K.; Lin, D.; Zhang, M.Y.; Bikle, D.D.; Shackleton, C.H.; Miller, W.L.; Portale, A.A. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin d-dependent rickets type 1. Mol. Endocrinol. 1997, 11, 1961-1970.
57. Schlingmann, K.P.; Kaufmann, M.; Weber, S.; Irwin, A.; Goos, C.; John, U.; Misselwitz, J.; Klaus, G.; Kuwertz-Broking, E.; Fehrenbach, H.; et al. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N. Engl. J. Med. 2011, 365, 410-421.
58. Jones, G.; Prosser, D.E.; Kaufmann, M. Cytochrome P450-mediated metabolism of vitamin D. J. Lipid Res. 2014, 55, 13-31.
59. Vogiatzi, M.G.; Macklin, E.A.; Fung, E.B.; Cheung, A.M.; Vichinsky, E.; Olivieri, N.; Kirby, M.; Kwiatkowski, J.L.; Cunningham, M.; Holm, I.A.; et al. Bone disease in thalassemia: A frequent and still unresolved problem. J. Bone Miner. Res. 2009, 24, 543-557.
60. Weinberg, E.D. Role of iron in osteoporosis. Pediatr. Endocrinol. Rev. 2008, 6 (Suppl. 1), 81-85.
61. Guggenbuhl, P.; Deugnier, Y.; Boisdet, J.F.; Rolland, Y.; Perdriger, A.; Pawlotsky, Y.; Chales, G. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos. Int. 2005, 16, 1809-1814.
62. Lee, K.S.; Jang, J.S.; Lee, D.R.; Kim, Y.H.; Nam, G.E.; Han, B.D.; Do Han, K.; Cho, K.H.; Kim, S.M.; Choi, Y.S.; et al. Serum ferritin levels are positively associated with bone mineral density in elderly Korean men: The 2008-2010 Korea National Health and Nutrition Examination Surveys. J. Bone Miner. Metab. 2014, 32, 683-690.
63. Kim, B.J.; Ahn, S.H.; Bae, S.J.; Kim, E.H.; Lee, S.H.; Kim, H.K.; Choe, J.W.; Koh, J.M.; Kim, G.S. Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: A 3-year retrospective longitudinal study. J. Bone Miner. Res. 2012, 27, 2279-2290.
64. Guggenbuhl, P.; Brissot, P.; Loreal, O. Miscellaneous non-inflammatory musculoskeletal conditions. Haemochromatosis: The bone and the joint. Best Pract. Res. Clin. Rheumatol. 2011, 25, 649-664.
65. Buyukbese, M.A.; Cetinus, E.; Cetinkaya, A.; Aras, S. Ferritin levels in postmenopausal women do not seem to play a significant role in osteoporosis. South. Med. J. 2005, 98, 845.
66. Terpos, E.; Voskaridou, E. Treatment options for thalassemia patients with osteoporosis. Ann. N. Y. Acad. Sci. 2010, 1202, 237-243.
67. De Sanctis, V.; Soliman, A.T.; Elsedfy, H.; Yassin, M.; Canatan, D.; Kilinc, Y.; Sobti, P.; Skordis, N.; Karimi, M.; Raiola, G.; et al. Osteoporosis in thalassemia major: An update and the I-CET 2013 recommendations for surveillance and treatment. Pediatr. Endocrinol. Rev. 2013, 11, 167-180.
68. Voskaridou, E.; Terpos, E. New insights into the pathophysiology and management of ossteoporosis in patients with beta thalasaemia. Br. J. Haematol. 2004, 127, 127-139.
69. Nakchbandi, I.A. Osteoporosis and fractures in liver disease: Relevance, pathogenesis and therapeutic implications. World J. Gastroenterol. 2014, 20, 9427-9438.
70. Miller, R.G.; Segal, J.B.; Ashar, B.H.; Leung, S.; Ahmed, S.; Siddique, S.; Rice, T.; Lanzkron, S. High prevalence and correlates of low bone mineral density in young adults with sickle cell disease. Am. J. Hematol. 2006, 81, 236-241.
71. Gupta, R.; Marouf, R.; Adekile, A. Pattern of bone mineral density in sickle cell disease patients with the high-Hb F phenotype. Acta Haematol. 2010, 123, 64-70.
72. Sarrai, M.; Duroseau, H.; D'Augustine, J.; Moktan, S.; Bellevue, R. Bone mass density in adults with sickle cell disease. Br. J. Haematol. 2007, 136, 666-672.
73. Reynolds, J. A re-evaluation of the “fish vertebra” sign in sickle cell hemoglobinopathy. Am. J. Roentgenol. Radium Ther. Nucl. Med. 1966, 97, 693-707.
74. Voskaridou, E.; Stoupa, E.; Antoniadou, L.; Premetis, E.; Konstantopoulos, K.; Papassotiriou, I.; Terpos, E. Osteoporosis and osteosclerosis in sickle cell/beta-thalassemia: The role of the rankl/osteoprotegerin axis. Haematologica 2006, 91, 813-816.
75. Valenti, L.; Varenna, M.; Fracanzani, A.L.; Rossi, V.; Fargion, S.; Sinigaglia, L. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos. Int. 2009, 20, 549-555.
76. Ebrahimpour, L.; Akhlaghpoor, S.; Azarkayvan, A.; Salehi, M.; Morteza, A.; Alinaghi, R. Correlation between bone mineral densitometry and liver/heart iron overload evaluated by quantitative T2* MRI. Hematology 2012, 17, 297-301.
77. Vogiatzi, M.G.; Macklin, E.A.; Fung, E.B.; Vichinsky, E.; Olivieri, N.; Kwiatkowski, J.; Cohen, A.; Neufeld, E.; Giardina, P.J. Prevalence of fractures among the thalassemia syndromes in North America. Bone 2006, 38, 571-575.
78. Chan, Y.L.; Pang, L.M.; Chik, K.W.; Cheng, J.C.; Li, C.K. Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: Predominance of osteoporosis and desferrioxamine-induced bone dysplasia. Pediatr. Radiol. 2002, 32, 492-497.
79. Vogiatzi, M.G.; Autio, K.A.; Schneider, R.; Giardina, P.J. Low bone mass in prepubertal children with thalassemia major: Insights into the pathogenesis of low bone mass in thalassemia. J. Pediatr. Endocrinol. Metab. 2004, 17, 1415-1421.
80. Shah, F.T.; Chatterjee, R.; Owusu-Asante, M.; Porter, J.B. Adults with severe sickle cell anaemia and iron overload have a high incidence of osteopenia and osteoporosis. Blood. 2004, 104, 468A-468A.
81. Tsay, J.; Yang, Z.; Ross, F.P.; Cunningham-Rundles, S.; Lin, H.; Coleman, R.; Mayer-Kuckuk, P.; Doty, S.B.; Grady, R.W.; Giardina, P.J.; et al. Bone loss caused by iron overload in a murine model: Importance of oxidative stress. Blood 2010, 116, 2582-2589.
82. Mahachoklertwattana, P.; Sirikulchayanonta, V.; Chuansumrit, A.; Karnsombat, P.; Choubtum, L.; Sriphrapradang, A.; Domrongkitchaiporn, S.; Sirisriro, R.; Rajatanavin, R. Bone histomorphometry in children and adolescents with beta-thalassemia disease: Iron-associated focal osteomalacia. J. Clin. Endocrinol. Metab. 2003, 88, 3966-3972.
83. Medeiros, D.M.; Stoecker, B.; Plattner, A.; Jennings, D.; Haub, M. Iron deficiency negatively affects vertebrae and femurs of rats independently of energy intake and body weight. J. Nutr. 2004, 134, 3061-3067.
84. Katsumata, S.; Tsuboi, R.; Uehara, M.; Suzuki, K. Dietary iron deficiency decreases serum osteocalcin concentration and bone mineral density in rats. Biosci. Biotechnol. Biochem. 2006, 70, 2547-2550.
85. Katsumata, S.; Katsumata-Tsuboi, R.; Uehara, M.; Suzuki, K. Severe iron deficiency decreases both bone formation and bone resorption in rats. J. Nutr. 2009, 139, 238-243.
86. Diaz-Castro, J.; Lopez-Frias, M.R.; Campos, M.S.; Lopez-Frias, M.; Alferez, M.J.; Nestares, T.; Ojeda, M.L.; Lopez-Aliaga, I. Severe nutritional iron-deficiency anaemia has a negative effect on some bone turnover biomarkers in rats. Eur. J. Nutr. 2012, 51, 241-247.
87. Harris, M.M.; Houtkooper, L.B.; Stanford, V.A.; Parkhill, C.; Weber, J.L.; Flint-Wagner, H.; Weiss, L.; Going, S.B.; Lohman, T.G. Dietary iron is associated with bone mineral density in healthy postmenopausal women. J. Nutr. 2003, 133, 3598-3602.
88. Maurer, J.; Harris, M.M.; Stanford, V.A.; Lohman, T.G.; Cussler, E.; Going, S.B.; Houtkooper, L.B. Dietary iron positively influences bone mineral density in postmenopausal women on hormone replacement therapy. J. Nutr. 2005, 135, 863-869.
89. D'Amelio, P.; Cristofaro, M.A.; Tamone, C.; Morra, E.; Di Bella, S.; Isaia, G.; Grimaldi, A.; Gennero, L.; Gariboldi, A.; Ponzetto, A.; et al. Role of iron metabolism and oxidative damage in postmenopausal bone loss. Bone 2008, 43, 1010-1015.
90. Blanco-Rojo, R.; Perez-Granados, A.M.; Toxqui, L.; Zazo, P.; de la Piedra, C.; Vaquero, M.P. Relationship between vitamin d deficiency, bone remodelling and iron status in iron-deficient young women consuming an iron-fortified food. Eur. J. Nutr. 2013, 52, 695-703.
91. Toxqui, L.; Perez-Granados, A.M.; Blanco-Rojo, R.; Wright, I.; de la Piedra, C.; Vaquero, M.P. Low iron status as a factor of increased bone resorption and effects of an iron and vitamin D-fortified skimmed milk on bone remodelling in young spanish women. Eur. J. Nutr. 2014, 53, 441-448.
92. Zhao, G.Y.; Zhao, L.P.; He, Y.F.; Li, G.F.; Gao, C.; Li, K.; Xu, Y.J. A comparison of the biological activities of human osteoblast hFOB1.19 between iron excess and iron deficiency. Biol. Trace Elem. Res. 2012, 150, 487-495.
93. Díaz-Castro, J.; Ramirez Lopez-Frias, M.; Campos, M.S.; Lopez-Frias, M.; Alferez, M.J.; Nestares, T.; Ortega, E.; Lopez-Aliaga, I. Goat milk during iron repletion improves bone turnover impaired by severe iron deficiency. J. Dairy Sci. 2011, 94, 2752-2761.
94. Kim, B.J.; Lee, S.H.; Koh, J.M.; Kim, G.S. The association between higher serum ferritin level and lower bone mineral density is prominent in women ≥45 years of age (KNHANES 2008-2010). Osteoporos. Int. 2013, 24, 2627-2637.
95. Wright, I.; Blanco-Rojo, R.; Fernandez, M.C.; Toxqui, L.; Moreno, G.; Perez-Granados, A.M.; de la Piedra, C.; Remacha, A.F.; Vaquero, M.P. Bone remodelling is reduced by recovery from iron-deficiency anaemia in premenopausal women. J. Physiol. Biochem. 2013, 69, 889-896.
96. Blanco-Rojo, R.; Perez-Granados, A.M.; Toxqui, L.; Gonzalez-Vizcayno, C.; Delgado, M.A.; Vaquero, M.P. Efficacy of a microencapsulated iron pyrophosphate-fortified fruit juice: A randomised, double-blind, placebo-controlled study in Spanish iron-deficient women. Br. J. Nutr. 2011, 105, 1652-1659.
97. Arnett, T.R.; Gibbons, D.C.; Utting, J.C.; Orriss, I.R.; Hoebertz, A.; Rosendaal, M.; Meghji, S. Hypoxia is a major stimulator of osteoclast formation and bone resorption. J. Cell. Physiol. 2003, 196, 2-8.
98. Shiozawa, Y.; Jung, Y.; Ziegler, A.M.; Pedersen, E.A.; Wang, J.; Wang, Z.; Song, J.; Wang, J.; Lee, C.H.; Sud, S.; et al. Erythropoietin couples hematopoiesis with bone formation. PLoS ONE 2010, 5, e10853.
99. Ilich-Ernst, J.Z.; McKenna, A.A.; Badenhop, N.E.; Clairmont, A.C.; Andon, M.B.; Nahhas, R.W.; Goel, P.; Matkovic, V. Iron status, menarche, and calcium supplementation in adolescent girls. Am. J. Clin. Nutr. 1998, 68, 880-887.
100. Hiram-Bab, S.; Liron, T.; Deshet-Unger, N.; Mittelman, M.; Gassmann, M.; Rauner, M.; Franke, K.; Wielockx, B.; Neumann, D.; Gabet, Y. Erythropoietin directly stimulates osteoclast precursors and induces bone loss. FASEB J. 2015, in press.
101. Lee, M.Y.; Fukunaga, R.; Lee, T.J.; Lottsfeldt, J.L.; Nagata, S. Bone modulation in sustained hematopoietic stimulation in mice. Blood 1991, 77, 2135-2141.
102. Okito, A.; Nakahama, K.I.; Akiyama, M.; Ono, T.; Morita, I. Involvement of the G-protein-coupled receptor 4 in RANKL expression by osteoblasts in an acidic environment. Biochem. Biophys. Res. Commun. 2015, doi:10.1016/j.bbrc.